These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
13-D SC 13G 8/21/2017
8-K 8-K 8/3/2017 8/3/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 8/3/2017 8/1/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; and Financial Statements and Exhibits.
10-Q 10-Q 8/3/2017 6/30/2017
8-K 8-K 6/29/2017 6/27/2017
Abstract: On June 27, registrant announced the pricing of an underwritten public offering of 2,807,017 shares of its common stock at a public offering price of $42.75 per share. The underwriting agreement and the opinion and consent of Goodwin Procter LLP were included by exhibit.
Prospectus 424B5 6/29/2017
8-K 8-K/A 6/26/2017 6/22/2017
Abstract: Registrant filed an amendment to the Form 8-K filed June 23 to provide the historical financial statements of Spectrum Inc. under Item 9.01(a) and the pro forma financial information required under Item 9.01(b).
Prospectus 424B5 6/26/2017
8-K 8-K 6/23/2017 6/22/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Entry into a Material Definitive Agreement; Regulation FD Disclosure; and Financial Statements and Exhibits.
8-K 8-K 5/23/2017 5/18/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holder; and Financial Statements and Exhibits.
8-K 8-K 5/4/2017 5/4/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-Q 10-Q 5/4/2017 3/31/2017
Proxy DEF 14A 4/21/2017 5/18/2017
Proxy PRE 14A 4/7/2017 5/18/2017
8-K 8-K/A 3/1/2017 12/14/2016
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Completion of Acquisition or Disposition of Assets and Financial Statements and Exhibits.
10-K 10-K 2/23/2017 12/31/2016
8-K 8-K 2/22/2017 2/22/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
13-D SC 13G/A 2/14/2017
13-D SC 13G/A 2/6/2017
13-D SC 13G/A 2/1/2017

Displaying 1 to 20 (of 119 filings)